No Matches Found

Loading...
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr

Sarda Proteins Ltd is Rated Strong Sell

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook.

Dec 29 2025 10:10 AM IST
share
Share Via
Sarda Proteins Ltd is Rated Strong Sell

Sarda Proteins Hits Intraday Low Amid Price Pressure and Market Headwinds

Sarda Proteins experienced a significant intraday decline, touching a low of Rs 74.11, reflecting a price pressure of 9.74% during today’s trading session. The stock’s performance contrasted sharply with broader market trends, highlighting immediate pressures within the edible oil sector.

Dec 29 2025 10:08 AM IST
share
Share Via
Sarda Proteins Hits Intraday Low Amid Price Pressure and Market Headwinds

Sarda Proteins Opens with Sharp Gap Down Amid Market Concerns

Sarda Proteins witnessed a significant gap down at the opening of trading today, with the stock price declining by 9.74% to open at Rs 74.11. This sharp drop reflects heightened market concerns within the edible oil sector, as the stock underperformed both its sector peers and the broader Sensex index.

Dec 29 2025 10:06 AM IST
share
Share Via
Sarda Proteins Opens with Sharp Gap Down Amid Market Concerns

Sarda Proteins Sees Revision in Market Assessment Amid Challenging Fundamentals

Sarda Proteins has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment highlights the evolving challenges faced by the edible oil company, particularly in its financial performance and valuation metrics.

Dec 10 2025 10:10 AM IST
share
Share Via
Sarda Proteins Sees Revision in Market Assessment Amid Challenging Fundamentals

Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses

Sarda Proteins Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.58% and exhibiting a complete absence of buyers. This distress selling comes amid a series of consecutive losses, signalling heightened market caution towards the edible oil company.

Dec 05 2025 12:45 PM IST
share
Share Via
Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses

Sarda Proteins Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

Sarda Proteins has captured market attention with an unusual trading pattern characterised by an upper circuit lock and exclusively buy orders in the queue. This rare phenomenon highlights intense demand for the stock, with no sellers willing to part with shares, signalling a potential multi-day circuit scenario that investors are closely monitoring.

Dec 05 2025 10:55 AM IST
share
Share Via
Sarda Proteins Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Losses

Sarda Proteins Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading floor. The edible oil company’s shares have recorded consecutive declines, reflecting distress selling signals that have intensified over recent months.

Dec 04 2025 02:01 PM IST
share
Share Via
Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Losses

How has been the historical performance of Sarda Proteins?

Sarda Proteins has shown significant sales growth, with net sales rising from 1.30 Cr in Mar'24 to 24.19 Cr in Mar'25, but faced challenges with increased expenditures, resulting in marginal operating profit and a decrease in profit after tax and EPS. Overall, while sales and total assets have grown, profitability remains a concern.

Dec 01 2025 11:28 PM IST
share
Share Via

Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Gains

Sarda Proteins Ltd, a key player in the edible oil sector, is currently experiencing extreme selling pressure with only sell orders present in the market queue. Despite a recent streak of gains, the stock’s trading activity today signals distress selling, raising concerns about its near-term outlook.

Dec 01 2025 11:20 AM IST
share
Share Via
Sarda Proteins Faces Intense Selling Pressure Amidst Consecutive Gains

Sarda Proteins Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit

Sarda Proteins has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust investor enthusiasm and raises the prospect of a sustained multi-day circuit scenario, setting it apart from sector peers and broader market trends.

Dec 01 2025 09:30 AM IST
share
Share Via
Sarda Proteins Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit

Sarda Proteins Surges with Unprecedented Buying Interest, Hits Upper Circuit

Sarda Proteins has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The edible oil company’s stock has recorded a remarkable run of consecutive gains, signalling strong investor enthusiasm and the potential for a multi-day circuit scenario.

Nov 28 2025 10:20 AM IST
share
Share Via
Sarda Proteins Surges with Unprecedented Buying Interest, Hits Upper Circuit

When is the next results date for Sarda Proteins?

The next results date for Sarda Proteins is 29 November 2025.

Nov 27 2025 11:15 PM IST
share
Share Via

Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses

Sarda Proteins Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers in the market. This extreme selling activity signals distress among investors, as the stock continues to face consecutive losses despite recent short-term gains.

Nov 27 2025 03:10 PM IST
share
Share Via
Sarda Proteins Faces Intense Selling Pressure Amid Consecutive Losses

Sarda Proteins Sees Unprecedented Buying Interest, Edges Into Multi-Day Upper Circuit

Sarda Proteins has witnessed extraordinary buying momentum, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust investor interest and the potential for a sustained multi-day circuit scenario, setting the edible oil sector abuzz.

Nov 26 2025 10:20 AM IST
share
Share Via
Sarda Proteins Sees Unprecedented Buying Interest, Edges Into Multi-Day Upper Circuit

Sarda Proteins Surges with Unprecedented Buying Interest, Edible Oil Sector Spotlight

Sarda Proteins has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a potential multi-day circuit scenario, setting the edible oil sector abuzz.

Nov 25 2025 02:40 PM IST
share
Share Via
Sarda Proteins Surges with Unprecedented Buying Interest, Edible Oil Sector Spotlight

Sarda Proteins Hits Upper Circuit Amidst Unprecedented Buying Interest

Sarda Proteins has surged to hit the upper circuit limit today, driven by extraordinary buying interest with no sellers in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand for the stock within the edible oil sector.

Nov 24 2025 09:40 AM IST
share
Share Via
Sarda Proteins Hits Upper Circuit Amidst Unprecedented Buying Interest

Sarda Proteins Stock Falls to 52-Week Low of Rs.59.95 Amidst Weak Financials

Sarda Proteins has reached a new 52-week low of Rs.59.95, marking a significant decline in its stock price over the past year. The edible oil company’s shares have underperformed considerably compared to the broader market, reflecting ongoing financial difficulties and subdued operational performance.

Nov 21 2025 09:55 AM IST
share
Share Via
Sarda Proteins Stock Falls to 52-Week Low of Rs.59.95 Amidst Weak Financials

Sarda Proteins Falls to 52-Week Low of Rs.59.95 Amidst Market Pressures

Sarda Proteins, a key player in the edible oil sector, touched a fresh 52-week low of Rs.59.95 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific factors.

Nov 21 2025 09:55 AM IST
share
Share Via
Sarda Proteins Falls to 52-Week Low of Rs.59.95 Amidst Market Pressures

Sarda Proteins Falls to 52-Week Low of Rs.59.95 Amidst Challenging Market Conditions

Sarda Proteins, a key player in the edible oil sector, touched a fresh 52-week low of Rs.59.95 today, marking a significant milestone in its recent price trajectory. This new low reflects ongoing pressures on the stock amid broader market movements and company-specific developments.

Nov 21 2025 09:55 AM IST
share
Share Via
Sarda Proteins Falls to 52-Week Low of Rs.59.95 Amidst Challenging Market Conditions

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
{{list.post_title_sep}}

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read